Repurposed GI Drugs in the Treatment of COVID-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
https://link.springer.com/content/pdf/10.1007/s10620-020-06430-z.pdf
Reference10 articles.
1. Kopel J, Perisetti A, Gajendran M, et al. Clinical insight into the gastrointestinal manifestations of COVID-19. Dig Dis Sci. 2020;. https://doi.org/10.1007/s10620-020-06362-8.
2. Bourinbaiar AS, Fruhstorfer EC. The effect of histamine type 2 receptor antagonists on human immunodeficiency virus (HIV) replication: Identification of a new class of antiviral agents. Life Sci. 1996;59(23):365–370.
3. Wu C, Liu Y, Yang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020;. https://doi.org/10.1016/j.apsb.2020.02.008.
4. Freedberg DE, Conigliaro J, Wang TC, et al. Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: A Propensity score matched retrospective cohort study. Gastroenterology. 2020;. https://doi.org/10.1053/j.gastro.2020.05.053.
5. Shen LW, et al. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie. 2017;142:1–10.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae;Frontiers in Pharmacology;2024-03-12
2. Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions;European Journal of Drug Metabolism and Pharmacokinetics;2023-04-24
3. A Brief Study on Drug Repurposing: New Way of Boosting Drug Discovery;Letters in Drug Design & Discovery;2023-03
4. Pharmaceutical Cocrystals of Famotidine: Structural and Biopharmaceutical Evaluation;Journal of Pharmaceutical Sciences;2022-10
5. Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm;Molecular Medicine;2022-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3